Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study
Phase of Trial: Phase I
Latest Information Update: 23 Feb 2016
At a glance
- Drugs Neosaxitoxin (Primary) ; Bupivacaine
- Indications Pain
- Focus Adverse reactions
- 16 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 26 Aug 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Feb 2015 Treatment arms have been changed from 3 to 4 and planned number patients have been changed from 77 to 84 as reported by ClinicalTrials.gov record.